Most people don’t know the many advances that the Department of Defense Congressionally Directed Medical Research Program (DOD PCRP) has brought to the PROSTATE CANCER COMMUNITY. Did you know that the program is directly responsible for funding the initial development of three of the very new drugs we have available?
The DOD PCRP is directly responsible for the development of:
ZYTIGA
XTANDI
XOFIGO
Without the funding from the DOD PCRP we would not have these life extending treatments!
Besides these drugs the DOD PCRP has funded other investigational treatments which are either in or preparing to enter into clinical trials. The DOD PCRP has also funded research that has led to the better understanding of the social and psychological implications of a diagnosis of PROSTATE CANCER.
The DOD PCRP funds a biorepository of high quality tissue that is available to a